Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -11.74 |
peg ratio | -4.45 |
price to book ratio | 7.08 |
price to sales ratio | 12.65 |
enterprise value multiple | -11.18 |
price fair value | 7.08 |
profitability ratios | |
---|---|
gross profit margin | 96.04% |
operating profit margin | -118.09% |
pretax profit margin | -108.62% |
net profit margin | -108.87% |
return on assets | -45.24% |
return on equity | -52.42% |
return on capital employed | -61.2% |
liquidity ratio | |
---|---|
current ratio | 4.19 |
quick ratio | 3.94 |
cash ratio | 1.09 |
efficiency ratio | |
---|---|
days of inventory outstanding | 1,111.38 |
operating cycle | 1,179.59 |
days of payables outstanding | 1,025.04 |
cash conversion cycle | 154.54 |
receivables turnover | 5.35 |
payables turnover | 0.36 |
inventory turnover | 0.33 |
debt and solvency ratios | |
---|---|
debt ratio | 0.06 |
debt equity ratio | 0.08 |
long term debt to capitalization | 0.06 |
total debt to capitalization | 0.07 |
interest coverage | -56.62 |
cash flow to debt ratio | -6.07 |
cash flow ratios | |
---|---|
free cash flow per share | -1.74 |
cash per share | 3.12 |
operating cash flow per share | -1.74 |
free cash flow operating cash flow ratio | 1.00 |
cash flow coverage ratios | -6.07 |
short term coverage ratios | -42.48 |
capital expenditure coverage ratio | -269.20 |
Frequently Asked Questions
Deciphera Pharmaceuticals, Inc. (DCPH) published its most recent earnings results on 10-05-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)'s trailing twelve months ROE is -52.42%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Deciphera Pharmaceuticals, Inc. (DCPH) currently has a ROA of -45.24%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
DCPH reported a profit margin of -108.87% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.19 in the most recent quarter. The quick ratio stood at 3.94, with a Debt/Eq ratio of 0.08.